CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Gebelik sürecinde paternal anti-HLA antikorların araştırılması
Gebelik, organ nakillerinde redlere sebep olan duyarlılaşma olaylarından biridir. Fetal hücreler tarafından ifade edilen paternal antijenlerin maternal immün sistem tarafından tanınması ile anti-HLA antikorları üretilir. Bu çalışmada İzmir Tepecik Eğitim
Mustafa SOYÖZ, Gürbüz, Burcu Çerçi
core
Abstract Natural killer (NK) cell neoplasms span indolent to highly aggressive entities, and flow cytometric immunophenotyping is central to their detection and classification. However, distinguishing reactive from neoplastic NK cell expansions can be challenging because NK cells lack somatically recombined antigen receptors, and reactive states may ...
Aaron J. Wilk +7 more
wiley +1 more source
Impact of preformed donor-specific anti-HLA antibodies on pancreatic islet transplantation outcomes: do they matter as they do in solid organ transplantation? [PDF]
Tawhari I +5 more
europepmc +1 more source
Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation. [PDF]
Muñoz-Herrera CM +2 more
europepmc +1 more source
Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu +3 more
wiley +1 more source
Anti-HLA antibodies in lung transplantation: diagnostic pitfalls and future directions. [PDF]
Zajacova A +8 more
europepmc +1 more source
The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).
Mimi Tang +11 more
wiley +1 more source
Editorial: Anti-HLA DSA and Beyond: Deciphering the Immunological Mechanisms Driving Chronic Rejection. [PDF]
Casiraghi F +5 more
europepmc +1 more source
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study. [PDF]
Zheng H +15 more
europepmc +1 more source

